1. Home
  2. Analysis

Weight decrease neonatal and drugs of ingredients of gabapentin (a real world drug study)


Summary:

Weight decrease neonatal is found among people who take drugs with ingredients of gabapentin, especially for people who are male, 0-1 old . This phase IV clinical study is created by eHealthMe based on reports of 415,239 people who have side effects when taking drugs with ingredients of gabapentin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Gabapentin, Gralise, Neurontin.

On Jun, 06, 2026

415,239 people reported to have side effects when taking drugs with ingredients of gabapentin.
Among them, 6 people (0.0%) have Weight decrease neonatal

What is Weight decrease neonatal?

Weight decrease neonatal is found to be associated with 25 drugs and 114 conditions by eHealthMe. Check the latest studies of Weight decrease neonatal.

Number of reports submitted per year:

Could drugs with ingredients of gabapentin cause Weight decrease neonatal?

Gender of people who have Weight decrease neonatal when taking drugs with ingredients of gabapentin *:

  • female: 20 %
  • male: 80 %

Age of people who have Weight decrease neonatal when taking drugs with ingredients of gabapentin *:

  • 0-1: 100 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 33.33%
  2. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 16.67%
  3. Alcohol Withdrawal Syndrome: 1 person, 16.67%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Folic Acid: 2 people, 33.33%
  2. Valproate Sodium: 1 person, 16.67%
  3. Atenolol: 1 person, 16.67%

Other side effects people have besides Weight decrease neonatal *:

You may use this to check any potential undetected side effects.

  1. Hypospadias (an abnormal condition in males in which the urethra opens on the under surface of the penis): 5 people, 83.33%
  2. Swallowing Difficulty: 5 people, 83.33%
  3. Growth Retardation (delayed growth): 5 people, 83.33%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 83.33%
  5. Foetal Anticonvulsant Syndrome (malformations and developmental delay in children due to intake of anticonvulsant drugs in pregnancy): 5 people, 83.33%
  6. Feeding Disorder (when children refuse to eat certain food groups): 5 people, 83.33%
  7. Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 5 people, 83.33%
  8. Drowsiness: 5 people, 83.33%
  9. Diplegia (paralysis of corresponding parts on both sides of the body): 5 people, 83.33%
  10. Developmental Delay: 5 people, 83.33%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of gabapentin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.